Inhibiting RANKL with denosumab increases bone mineral density in patients with rheumatoid arthritis: 6-month results from a randomized, placebo-controlled trial
ANNALS OF THE RHEUMATIC DISEASES（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要